Mehra Uneek 4
4 · BridgeBio Oncology Therapeutics, Inc. · Filed Aug 28, 2025
Insider Transaction Report
Form 4
Mehra Uneek
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-08-26+633,570→ 633,570 totalExercise: $9.59Exp: 2035-08-25→ Common Stock (633,570 underlying)
Footnotes (1)
- [F1]25% of the shares underlying such option shall vest on July 21, 2026, with the remainder vesting in thirty-six substantially equal monthly installments thereafter, subject to the Reporting Person's continuous service the Issuer on each such vesting date.